EditorsAbout the SiteComes vs. MicrosoftUsing This Web SiteSite ArchivesCredibility IndexOOXMLOpenDocumentPatentsNovellNews DigestSite NewsRSS

03.06.08

USPTO As Broken as Always, Proof Herein

Posted in Free/Libre Software, Hardware, Patents at 2:03 am by Dr. Roy Schestowitz

Repeating the same mistakes of the drug industry

Whenever you find comfort in the belief that you have seen enough, here comes another disturbance. This one is from RIM.

What do you get if you mesh a dual-orientation handset together with a slide-out keyboard and a tracker ball? Potentially, the next BlackBerry from Research in Motion (RIM), if its latest patent application is anything to go by.

USPTOWhat RIM patents here has plenty of prior art and we recently saw an incident where RIM actually sued unnecessarily, attacking a weaker company like Motorola using weak patents applicable to wireless communication standards. The Nokia N810 and the Mylo from Sony seem rather similar to the design in this patent application, but this does not seem to bother or deter RIM. Remember what these people think: More Patents = More Innovation. But not so fast!

It seems like a patents blog has just shown up (or been born) in C|Net and it now speaks about the “first-to-file” rule, which renders the whole system utterly pointless and prone to error.

Generally, the first person to file the lawsuit gets to choose where the suit is brought. This is called the “first-to-file” rule. It works much like the lines you stand in at the grocery store, airport security, or countless other places; it’s simply first come, first served.

However, in the context of patent litigation, being first in line is a big deal. Different courts have different procedural rules that can affect the way a case is litigated and the speed at which the case goes to trial. Moreover, there is a perception that courts in certain areas are more plaintiff-friendly than others.

The term “first-to-file” is used in numerous other circumstances which equally well demonstrate the weakness of the whole approach. The pharmaceutical industry is already learning its lessons, so why can’t others?

Below we’re appending some relevant and recent stories about conclusions arrived by drug companies and biologists. They are sorted reverse-chronologically (roughly).


1. Open Lab

The open source wave could soon power drug discovery initiatives in the country. A decentralised, web-based initiative is emerging that would enable scientists from laboratories, universities, institutes, and drug Companies to work together in discovering new drugs for diseases like tuberculosis (TB), malaria, various types of cancer, AIDS, Chikungunya, Kala-azar, dengue fever, etc.

2. Open-source model for drug discovery?

Significant public funding along with the ability for private enterprise to benefit from the open source approach will result in a strong public-private partnership and ensure success of the open source approach.

3. Open source drug discovery

The idea, taking off from successful open source models such as the human genome sequencing initiative, is very simple. All the relevant data and accumulated intelligence on a particular disease, tuberculosis to begin with, would be hosted online.

4. ‘Open source’ urged for TB drug design effort

One of India’s top genetics researchers has called for a global, collaborative effort to design a new tuberculosis (TB) drug using an ‘open source’ approach.

5. Open Source Pharmaceuticals – New Business Model

Software is not the only field affected by open source; many fields of study and social and political views have been affected by the growth of the concept of open source. Advocates in one field will often support the expansion of open source in other fields, including Linus Torvalds who is quoted as saying, “the future is open source everything.”

6. Open source synthetic biology

Not everyone within synthetic biology takes the open-source approach, Andrew Hessel, an iGEM consultant who recruits teams from Canadian universities, told me, but the driving force behind it is iGEM and MIT (Rettberg works with renowned hacker-turned-synthetic biologist Tom Knight). Hessel likened the atmosphere to the time when computers were first becoming cheap enough to be affordable by anyone who wanted one, and young, bright kids began to play around with code.

7. Biology Goes Open Source

Some of the world’s biggest drug companies are finding that their genetic research is worth more to them if they give it away.

8. Pharmac publishes directly with open source

The team used Python, libxml/libxslt and TeX, running on Debian GNU/Linux, and the open document standards TeX, XML, MathML, XHTML, and Xlink, says Geering.

9. Open Source Research — the Power of Us

Open source methods have delivered tangible benefits in the computer science community. We describe here efforts to extend these principles to science generally, and in particular biomedical research. Open source research holds great promise for solving complex problems in areas where profit-driven research is seen to have failed. We illustrate this with a specific problem in organic chemistry that we think will be solved substantially faster with an open source approach.

10. Our Biotech Future [is Open Source]

Open Source biology could be a powerful tool, giving us access to cheap and abundant solar energy.

11. Open-Source Drug Safety?

More than a million Americans take Avandia every year; the risk Glaxo had found would mean thousands of extra heart attacks. But the company argued that the risk only occurred in patients who already had serious heart problems, and that it didn’t show up in long-term clinical trials. The FDA made no decision, and no public statement.

[...]

It’s an open source approach to drug safety.

12. Open Source Pharmaceuticals – New Business Model

“Open source” as applied to culture defines a culture in which intellectual property is made generally available. Participants in such a culture are able to improve and modify those products and redistribute them back into the community.

13. Thailand fed up with high drug prices – minister

“We have thought about this for more than five years. It’s long enough,” said Mongkol na Songkhla, who is leading one of the biggest challenges to Big Pharma’s patent rights in years.

In relation to this:

“Collaboration reduces development costs and subsequent high prices, and therefore precludes the need for patents. Took them long enough to figure that out, didn’t it?”

Slated, March 4th 2008

Time for change. Software patents do more harm than good.

Share this post: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Reddit
  • co.mments
  • DZone
  • email
  • Google Bookmarks
  • LinkedIn
  • NewsVine
  • Print
  • Technorati
  • TwitThis
  • Facebook

If you liked this post, consider subscribing to the RSS feed or join us now at the IRC channels.

Pages that cross-reference this one

A Single Comment

  1. mcintosh said,

    March 6, 2008 at 7:58 am

    Gravatar

    You want proof that our patent system is broken? Look up US patent number 6,960,975. Not only is there a metric (donkey)load of prior conceptual art in at least a half century’s science fiction, but reduction to practice is not presently possible.

What Else is New


  1. IRC Proceedings: Thursday, December 05, 2019

    IRC logs for Thursday, December 05, 2019



  2. Links 5/12/2019: qBittorrent 4.2.0, Expensive Librem 5 and OpenBSD Bugs

    Links for the day



  3. Microsoft Staff Repeatedly Refuses to Tell How Many People Use WSL, Defends Patent Extortion and Blackmail of Linux Instead

    The people who develop WSL (mostly Microsoft employees) get easily irritated when asked how many people actually use this thing; but more interestingly, however, they reveal their disdain for GNU/Linux and support for Microsoft blackmail (for 'Linux patent tax')



  4. IRC Proceedings: Wednesday, December 04, 2019

    IRC logs for Wednesday, December 04, 2019



  5. Links 4/12/2019: Tails 4.1, UCS 4.4-3 and Proxmox VE 6.1

    Links for the day



  6. Google Tightens Its Noose

    Now it’s official! Google is just a bunch of shareholders looking to appease the Pentagon at all costs



  7. Europeans Still Need to Save the European Patent Office From Those Who Attack Its Patent Quality

    Patent quality is of utmost interest; without it, as we're seeing at the EPO and have already seen at the USPTO for a number of years, legal disputes will arise where neither side wins (only the lawyers win) and small, impoverished inventors or businesses will be forced to settle outside the courts over baseless allegations, often made by parasitic patent trolls (possessing low-quality patents they don't want scrutinised by courts)



  8. We Never Accepted and Will Never Accept Corporate Money

    Corporate money is a unique problem because of its magnitude and the fact that it's impersonal; shareholders can only ever accept its supposed justifications if they're receiving something in return (of proportional worth to the payment/transaction)



  9. IRC Proceedings: Tuesday, December 03, 2019

    IRC logs for Tuesday, December 03, 2019



  10. Links 3/12/2019: elementary OS 5.1 Hera, Plasma 5.17.4, Firefox 71

    Links for the day



  11. Laundering the Reputation of Criminals: That's an Actual Job

    An important reminder that the manufactured, paid-for (media is being bribed) image of Bill Gates is the product of the PR industry he enlisted to distract from his endless crimes



  12. 'Priceless' Tickets to the EPO's Back End and Team UPC

    CIPA's and the EPO's event (later this week) is more of the same; the EPO exists not to serve European businesses but a bunch of law firms and their biggest clients (which usually aren't even European)



  13. IRC Proceedings: Monday, December 02, 2019

    IRC logs for Monday, December 02, 2019



  14. New EPO Leak Shows That the Rumours and Jokes Are Partly True and We Know Who 'Runs the Show'

    Europe’s second-largest institution is so profoundly dysfunctional, a reprehensible kakistocracy of tribalism, money-grabbing career-climbing autocrats and possibly major fraud; today’s leak looks at what motivated and enabled the formation and latest incarnation of “Team Campinos”



  15. Links 2/12/2019: Linux Mint 19.3 Beta, DPL Sam Hartman Talks About SystemD

    Links for the day



  16. What Former Debian Project Leader (Second to the Late Ian Murdock) Thinks About SystemD in Debian GNU/Linux

    Now that Debian is debating and voting on diversity in the technical sense the thoughts of Bruce Perens merit broader audience/reach



  17. Free/Libre Software Will Eventually Become the Norm, 'Open Source' is Just Proprietary Software Trying to 'Buy Time'

    More people are starting to ask questions about Free software while “Open Source” languishes (people can see it’s just a mask for proprietary software); it was a two-decade delaying tactic that’s wearing off (people see GitHub and the OSI/Linux Foundation for what they really are)



  18. IRC Proceedings: Sunday, December 01, 2019

    IRC logs for Sunday, December 01, 2019



  19. Richard Stallman is Active and Doing Well

    The rumour mill may still be humming along; but against all odds — as Chief GNUisance of the GNU Project — Stallman keeps fighting the good fight (in the face of growing resistance)



  20. Banning Former Microsoft Employees Who Complain About Microsoft Lies, Abuses and Crimes

    The official account of Windows Insider is banning people whom it never even spoke to; this seems like a way of 'punishing' people who are not 'true believers' in Microsoft



  21. Wikileaks: Thierry Breton May Have Misused Regulatory/Government Positions to Attack His Competition (in the Market)

    Thierry 'revolving doors' Breton as seen by the United States government



  22. 13 Years of UPC Promises

    The anatomy of UPC 'fake news' or lobbying tactics along the lines of self-fulfilling prophecies and false predictions



  23. Is Water Wet?

    The criteria for patent eligibility reduced only to this question: will allowing these patents increase ‘production’ (number of patent grants)?



  24. The EPO's President Admits He's Illegally Granting Software Patents (CII, 4IR, IoT, AI and Blockchain Mean Software Patents at the EPO)

    The EPO's chief liar is openly and proudly promoting software patents using buzzwords and hype waves (and mysterious acronyms that are rather meaningless but spread by the media in exchange for money received from the EPO)



  25. Tone Policing and the Linux Foundation

    A timely example of situations where the Linux Foundation can seemingly 'cancel' people (using the Code of Conduct) for political opinions



  26. It EEEsn't Just a Microsoft Thing Anymore

    The EEErosion of Python's independence is a known problem and Microsoft is not the sole culprit



  27. Links 1/12/2019: KDE's GTK CSD Support, Skrooge 2.21.0

    Links for the day



  28. Links 1/12/2019: Genode OS 19.11 Release, Sam Hartman (DPL) Speaks Out on SystemD

    Links for the day



  29. Maximalists Cherry-Picking the So-Called 'Corbyn' 'Leak' for Their Patent Agenda While the US Lobbies Britain for Software Patents and Worse

    A quick look at what last week's media coverage may have missed and what patent maximalists don't want to tell us about confidential trade-related documents



  30. IRC Proceedings: Saturday, November 30, 2019

    IRC logs for Saturday, November 30, 2019


RSS 64x64RSS Feed: subscribe to the RSS feed for regular updates

Home iconSite Wiki: You can improve this site by helping the extension of the site's content

Home iconSite Home: Background about the site and some key features in the front page

Chat iconIRC Channel: Come and chat with us in real time

Recent Posts